The company
Abmart is the “$1000 monoclonal antibody” company: in the next 2-3 years, we will become the first company to enable the development of monoclonal antibodies in ~3 months and under $1000. Through technology innovations and system engineering, Abmart is building industrialized, standardized assembly lines to produce monoclonal antibodies at a fraction of current cost. Abmart will enable antibody users to purchase catalog antibodies or make new monoclonal antibodies at will.
Founded by experienced life science entrepreneurs and venture capital firms, Abmart has assembled a first-class team and has built a state-of-the-art antibody research and production facility in Shanghai. Abmart will have the capacity to produce over 1000 monoclonal antibodies in 2010.
Service
Abmart now offers to develop custom “Application Guaranteed” monoclonal antibodies for ELISA, Western blot, IP, IF, ICC, IHC and other applications. Abmart promises to provide our customers with the best antibody experience in the industry.
Team
- • A strong management team of experienced life science entrepreneurs
- • A team of 70 scientists(~15% are Ph.D.s)
Facility
- • 10,000 sqf production space located in Shanghai
- • A separate animal facility with capacity for 5000 rabbits and 10,000 mice
Antibody Experience
- • Have successfully developed over 1000 “Application Guaranteed” monoclonal and polyclonal antibodies
- • Antigens including recombinant proteins, modified peptides and small molecule haptens
- • Experienced in antibody development for proteins from human, mouse, Drosophila, C. elegans, Zebra fish, Arabidopsis,bacteria and viruses
